Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Clinical and Experimental Rheumatology|February 5, 2016
A randomised trial evaluating anakinra in early active rheumatoid arthritisIan C Scott, Fowzia Ibrahim, Gemma Simpson, et al.Plos One|August 31, 2021
Risk factors for treatment failure in women with uncomplicated lower urinary tract infectionRomain Martischang, Maciek Godycki-Ćwirko, Anna Kowalczyk, et al.Antibiotics (Basel, Switzerland)|November 11, 2022
Developing a Tool for Auditing the Quality of Antibiotic Dispensing in Community Pharmacies: A Pilot StudyMaarten Lambert, Ria Benkő, Athina Chalkidou, et al.Journal of the American Medical Directors Association|December 4, 2019
Antibiotic Stewardship in European Nursing Homes: Experiences From the Netherlands, Norway, Poland, and SwedenLaura W Van Buul, Annelie A Monnier, Pär-Daniel Sundvall, et al.Plos One|July 9, 2014
Tailored implementation of evidence-based practice for patients with chronic diseasesMichel Wensing, Elke Huntink, Jan van Lieshout, et al.Lung Cancer (Amsterdam, Netherlands)|February 26, 2026
Mutational landscapes of brain metastases across various histological subtypes of lung cancerMarcin Nicoś, Tomasz Stokowy, Katarzyna Reszka, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2006
Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs)Barbara Alicja Jereczek-Fossa, Federica Cattani, Alberto D'Onofrio, et al.The Journal of Antimicrobial Chemotherapy|March 14, 2015
Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiotaJascha Vervoort, Basil Britto Xavier, Andrew Stewardson, et al.Antimicrobial Agents and Chemotherapy|September 24, 2014
An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coliJascha Vervoort, Basil Britto Xavier, Andrew Stewardson, et al.World Journal of Gastroenterology|July 26, 2013
Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylationPiotr M Wierzbicki, Krystian Adrych, Dorota Kartanowicz, et al.Pageof 13